Long-term outcome of patients with chronotropic incompetence after an acute myocardial infarction

Antti M Kiviniemi1, Mikko P Tulppo, Arto J Hautala

  • 1Department of Exercise and Medical Physiology, Verve Research, Oulu, Finland. Antti.Kiviniemi@verve.fi

Annals of Medicine
|October 28, 2010
PubMed

Insights

Chronotropic incompetence, a measure of heart rate response to exercise, is a strong predictor of cardiac death in patients after a myocardial infarction (MI). This finding aids in risk stratification for post-MI mortality.

Area of Science:

  • Cardiology
  • Clinical Medicine
  • Exercise Physiology

Background:

  • Chronotropic incompetence is a known mortality risk marker in general populations.
  • Its predictive value in patients post-myocardial infarction (MI) remains unestablished.
  • Risk stratification is crucial for managing post-MI patients.

Purpose of the Study:

  • To investigate the prognostic value of chronotropic incompetence in patients with recent MI.
  • To determine if chronotropic incompetence predicts cardiac death and sudden cardiac death (SCD) in this cohort.
  • To compare its predictive power against established markers like left ventricular ejection fraction (LVEF).

Main Methods:

  • A cohort of 494 patients with recent MI underwent exercise testing and echocardiography.
  • Maximal chronotropic response index (CRI) was calculated to assess heart rate response to exercise.
  • Cardiac death and SCD were tracked over an 8-year follow-up period.

Main Results:

  • Abnormal CRI (<39) was the strongest predictor of cardiac death (adjusted RR 5.4) and SCD (adjusted RR 7.3).
  • Decreased LVEF (<45%) also predicted cardiac death (adjusted RR 3.4).
  • Excluding CRI from the predictive model significantly reduced its accuracy (c-index decreased from 0.817 to 0.778).

Conclusions:

  • Chronotropic incompetence is a powerful and independent predictor of cardiac mortality in post-MI patients.
  • CRI offers significant value in risk stratification beyond traditional markers like LVEF.
  • This highlights the importance of assessing heart rate response to exercise in MI survivors.
Abstract

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...